Publicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (5)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

    Gates Open Research, Vol. 6

  2. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control

    The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414